Valuation: Bio-Rad Laboratories, Inc.

Market Cap 10.06B 9.17B 8.48B 7.65B 14.41B 940B 14.98B 102B 40.48B 507B 37.72B 36.93B 1,601B P/E 2026 *
44.5x
P/E 2027 * 43.5x
Enterprise Value 9.31B 8.49B 7.85B 7.08B 13.34B 870B 13.86B 94.78B 37.46B 469B 34.91B 34.18B 1,482B EV / Sales 2026 *
3.62x
EV / Sales 2027 * 3.49x
Free-Float
60.27%
Yield 2026 *
-
Yield 2027 * -
1 day+3.34%
1 week-4.10%
Current month-0.54%
1 month+4.66%
3 months+4.96%
6 months+31.35%
Current year+22.17%
1 week 356.5
Extreme 356.5
373.5
1 month 347.29
Extreme 347.29
394.73
Current year 236.73
Extreme 236.73
396.23
1 year 236.73
Extreme 236.73
396.23
3 years 211.43
Extreme 211.43
396.23
5 years 211.43
Extreme 211.43
774.87
10 years 169.18
Extreme 169.185
832.7
Manager TitleAgeSince
Chief Executive Officer 76 01/01/2003
President 61 09/09/2024
Director of Finance/CFO 55 15/04/2024
Director TitleAgeSince
Chairman 76 01/01/2012
Director/Board Member 73 25/04/2017
Director/Board Member 79 25/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
24/10/26 Exercice

Chairperson

4,689 0.0216%
20/10/26 Exercice

Executive/Senior Manager

2,575 0.0119%
6/9/26 Exercice

General Counsel

1,841 0.0085%
Change 5-day change 1-year change 3-year change Capi.($)
+3.34%-4.10%+20.27%+23.65% 10.06B
-0.22%-4.40%-19.63%+4.95% 181B
-1.56%-0.88%-0.08%+34.72% 123B
+0.19%-0.20%-11.51%+10.32% 121B
-0.61%-0.14%-41.80%+1.74% 91.11B
-0.64%-0.45%-3.69%+78.62% 66.47B
+0.31%+0.73%+12.35%-7.37% 58.86B
+1.19%-0.59%+4.22%+50.63% 55.03B
+0.38%-2.16%+3.38%+42.16% 48.88B
+0.72%+4.15%+3.77%-0.35% 35.5B
Average +0.31%-0.67%-3.27%+23.91% 79B
Weighted average by Cap. -0.19%-1.16%-9.54%+20.79%

Financials

2026 *2027 *
Net sales 2.57B 2.34B 2.17B 1.96B 3.68B 240B 3.83B 26.17B 10.34B 130B 9.64B 9.44B 409B 2.61B 2.38B 2.2B 1.98B 3.74B 244B 3.88B 26.55B 10.49B 131B 9.78B 9.58B 415B
Net income 225M 205M 190M 171M 322M 21.01B 335M 2.29B 905M 11.34B 844M 826M 35.81B 230M 210M 194M 175M 329M 21.47B 342M 2.34B 925M 11.59B 862M 844M 36.59B
Net Debt -749M -683M -632M -570M -1.07B -69.99B -1.12B -7.63B -3.02B -37.78B -2.81B -2.75B -119B -965M -880M -814M -735M -1.38B -90.21B -1.44B -9.83B -3.89B -48.69B -3.62B -3.55B -154B
Projected Income Statement - Annual - Bio-Rad Laboratories, Inc.
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
18/11/26 USD 370.17 +3.34% 460,475
17/11/26 USD 358.19 -0.57% 202,630
16/11/26 USD 360.26 -1.67% 169,944
13/11/26 USD 366.36 -1.11% 256,211
12/11/26 USD 370.48 -4.02% 182,322
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bio-Rad Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
370.17USD
Average target price
356.67USD
Spread / Average Target
-3.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bio-Rad Laboratories, Inc.